Compare MPX & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPX | OABI |
|---|---|---|
| Founded | 1965 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.2M | 277.8M |
| IPO Year | N/A | N/A |
| Metric | MPX | OABI |
|---|---|---|
| Price | $8.17 | $1.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 43.7K | ★ 424.6K |
| Earning Date | 02-05-2026 | 03-17-2026 |
| Dividend Yield | ★ 6.93% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $244,419,000.00 | $21,094,000.00 |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $13.02 | $66.20 |
| P/E Ratio | $25.25 | ★ N/A |
| Revenue Growth | 3.32 | ★ 3.36 |
| 52 Week Low | $7.49 | $1.22 |
| 52 Week High | $10.08 | $4.02 |
| Indicator | MPX | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 34.26 | 49.80 |
| Support Level | $9.23 | $1.67 |
| Resistance Level | $10.00 | $1.86 |
| Average True Range (ATR) | 0.40 | 0.11 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 5.05 | 45.16 |
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.